Travaux scientifiques

Prof. Dr. Ömer Fatih Ölmez

163 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. 2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.1314 Texte intégral en libre accèsSource : OpenAlex

  2. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

    Lung Cancer, 2020

    DOI 10.1016/j.lungcan.2020.07.022 PMID 32799090 30 citations (Europe PMC) Source : OpenAlex

  3. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

    European Urology Focus, 2020

    DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 citations (Europe PMC) Source : ORCID

  4. Papilledema: Could It Be an Important Clinical Sign of Leptomeningeal Metastasis?

    Medical Bulletin of Haseki, 2020

    DOI 10.4274/haseki.galenos.2020.6190 Texte intégral en libre accèsSource : ORCID

  5. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.6_suppl.451 3 citations (OpenAlex) Source : OpenAlex

  6. 781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.853 Texte intégral en libre accèsSource : OpenAlex

  7. P1.14-01 Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1152 Texte intégral en libre accèsSource : OpenAlex

  8. P2.01-64 Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1407 Texte intégral en libre accèsSource : OpenAlex

  9. Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?

    Van Yüzüncü Yıl University Academic Data Management System, 2019

    Source : OpenAlex

  10. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy

    Oncology Research and Treatment, 2019

    DOI 10.1159/000496746 PMID 30870846 18 citations (Europe PMC) Source : OpenAlex

  11. Platelet to lymphocyte ratio is associated with tumour localization and outcomes in patients with metastatic colorectal cancer

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz421.042 Texte intégral en libre accèsSource : OpenAlex

  12. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1166 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  13. Is there any prognostic significance in pleural involvement and/or effusion (Ple-I/E) in patients with ALK-positive NSCLC?

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz260.069 Texte intégral en libre accèsSource : OpenAlex

  14. metastatik meme kanseri tedavisindelapatinib kapesitabinkombinasyonunun retrospektif değerlendirilmesi

    Bursa Uludag University - AVESIS, 2019

    Source : OpenAlex

  15. Mide Kanserlerinde İmmünoterapiler: PD-1 ve PD-L1 İnhibitörleri

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source : OpenAlex

  16. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade

    Journal of Oncology Pharmacy Practice, 2018

    DOI 10.1177/1078155218792672 PMID 30124121 6 citations (Europe PMC) Source : OpenAlex

  17. P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.601 Texte intégral en libre accèsSource : OpenAlex

  18. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experince from Turkey

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source : OpenAlex

  19. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

    Bursa Uludag University - AVESIS, 2018

    Source : OpenAlex

  20. CRIZOTINIB EFFICACY IN ALK-POSITIVE ADVANCEDSTAGE NON-SMALL CELL LUNG CANCER PATIENTS: A REAL-WORLD EXPERIENCE FROM TURKEY

    Kocaeli Üniversitesi - AVESİS, 2018

    Source : OpenAlex

  21. Metastatik Meme Kanseri Tedavisinde Lapatinib Kapesitabin Kombinasyonun Etkinliğinin Retrospektif Değerlendirilmesi

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2018

    DOI 10.32708/uutfd.485507 Texte intégral en libre accèsSource : OpenAlex

  22. Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.10.001 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  23. The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey

    AYBU AVESIS, 2018

    Source : OpenAlex

  24. Kanserde Palyatif Tedaviler: Palyatif Kemoterapi Uygulamaları

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Source : OpenAlex

  25. P2.01-063 Outcomes of Patients with Oligometastatic Non-Small Cell Lung Cancer Who Were Treated with Radical Treatment

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.1165 Texte intégral en libre accèsSource : OpenAlex

  26. Immunohistochemical expression of human epidermal growth factor receptor (HER)-4 and prognosis in patients with metastatic breast cancer.

    PubMed, 2016

    PMID 27569073 Source : OpenAlex

  27. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?

    Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2015

    PMID 26214622 36 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  28. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival

    Asian Pacific Journal of Cancer Prevention, 2015

    DOI 10.7314/apjcp.2015.16.4.1643 PMID 25743846 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  29. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy

    Journal of B.U.ON., 2015

    PMID 26416041 10 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  30. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.

    PubMed, 2015

    PMID 25778295 20 citations (OpenAlex) Source : OpenAlex

  31. Association and Prognostic Significance of the Functional −1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer

    Pathology & Oncology Research, 2015

    DOI 10.1007/s12253-015-9950-7 PMID 26156886 9 citations (OpenAlex) Source : OpenAlex

  32. Metastatik Böbrek Kanserinde Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2015

    Source : OpenAlex

  33. Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer

    Współczesna Onkologia, 2014

    DOI 10.5114/wo.2014.40454 PMID 24876819 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  34. Cisplatin Plus Etoposide in the Adjuvant Treatment of Patients with Non-Small Cell Lung Cancer

    The Annals of Clinical and Analytical Medicine, 2014

    DOI 10.4328/jcam.1469 Texte intégral en libre accèsSource : OpenAlex

  35. Efficacy of Sunitinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

    The Annals of Clinical and Analytical Medicine, 2014

    DOI 10.4328/jcam.1375 Source : OpenAlex

  36. Malignant melanoma of the stomach in an elderly patient

    The Turkish Journal of Gastroenterology, 2014

    DOI 10.5152/tjg.2014.3845 PMID 25910348 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  37. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.

    PubMed, 2013

    PMID 23818346 4 citations (Europe PMC) Source : OpenAlex

  38. Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.7.4115 PMID 23991962 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  39. Lokal İleri veya Metastatik Pankreas Kanserli Hastalarımızın Retrospektif Değerlendirilmesi

    DergiPark (Istanbul University), 2013

    Texte intégral en libre accèsSource : OpenAlex

  40. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer.

    PubMed, 2013

    PMID 23613400 3 citations (OpenAlex) Source : OpenAlex

  41. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme

    Clinical & Translational Oncology, 2013

    DOI 10.1007/s12094-013-1059-4 PMID 23740136 25 citations (OpenAlex) Source : OpenAlex

  42. The SOCS-1 -1478CA/del Polymorphism is not Associated with Colorectal Cancer or Age at Onset in Turkish Subjects

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.12.7583 PMID 24460337 5 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  43. Rektum Kanserinde Sistemik Kemoterapi Uygulamaları

    Bursa Uludag University - AVESIS, 2013

    Source : OpenAlex

  44. Küçük Hücreli Akciğer Kanserli Bir Hastada Ektopik ACTH Sendromu: Olgu Sunumu

    DergiPark (Istanbul University), 2013

    Texte intégral en libre accèsSource : OpenAlex

  45. LOKAL İLERİ VEYA METASTAİK PANKREAS KANSERLİ HASTALARIMIZIN RETROSPEKTİF DEĞERLENDİRİLMESİ

    Bursa Uludag University - AVESIS, 2013

    Source : OpenAlex

  46. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer

    Clinical & Translational Oncology, 2012

    DOI 10.1007/s12094-012-0921-0 PMID 22911549 17 citations (Europe PMC) Source : OpenAlex

  47. Pulmonary Actinomycosis Mimicking Metastasis from Lung Adenocarcinoma

    Onkologie, 2012

    DOI 10.1159/000342675 PMID 23038234 2 citations (Europe PMC) Source : OpenAlex

  48. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors.

    PubMed, 2012

    PMID 23033292 Source : OpenAlex

  49. PharmaNews / PharmaTicker

    Onkologie, 2012

    DOI 10.1159/000312582 Texte intégral en libre accèsSource : OpenAlex

  50. Meetings and Conferences · Tagungen und Kongresse

    Onkologie, 2012

    DOI 10.1159/000178528 Texte intégral en libre accèsSource : OpenAlex